NOS2 and myeloid sarcoma: Although iNOS is increased in macrophages, activated microglia, astrocytes, and oligodendrocytes surrounding MS lesions, it is its conversion to ONOO- that is damaging to cells in MS [51], including oligodendrocytes [52].